Holen Sie sich die Stockscreener-App
12.00
3.36%
0.39
Handel nachbörslich:
12.00
Xencor Inc Aktie (XNCR) Neueste Nachrichten
Xencor’s Lung Cancer Trial Halted: What the Vudalimab Update Means for XNCR Investors - TipRanks
Jefferies Financial Group Inc. Takes Position in Xencor, Inc. $XNCR - MarketBeat
Xencor at Barclays Healthcare Conference: Pipeline Progress and Strategic Plans - Investing.com India
(XNCR) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Xencor at Leerink Global Healthcare: Strategic Development Insights - Investing.com Nigeria
Xencor, Inc. (NASDAQ:XNCR) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Xencor SVP Eckert sells $17,747 in shares - Investing.com Nigeria
Xencor faces royalty dispute with Alexion over Ultomiris sales - Investing.com Nigeria
Xencor (NASDAQ:XNCR) CEO Sells $72,798.12 in Stock - MarketBeat
John Desjarlais Sells 4,118 Shares of Xencor (NASDAQ:XNCR) Stock - MarketBeat
Xencor (NASDAQ:XNCR) SVP Sells $19,472.34 in Stock - MarketBeat
Xencor (NASDAQ:XNCR) SVP Celia Eckert Sells 3,244 Shares - MarketBeat
Xencor (NASDAQ:XNCR) VP Sells $27,572.04 in Stock - MarketBeat
Xencor (NASDAQ:XNCR) CEO Bassil Dahiyat Sells 14,870 Shares - MarketBeat
Xencor, Genentech to End Protein Therapeutics Collaboration - TipRanks
Royalty rift: Alexion cuts off US royalty payments to Xencor - MSN
Market Moves: What is the Moat Score of Xencor IncMarket Volume Summary & Weekly Watchlist of Top Performers - baoquankhu1.vn
Is Xencor Inc a strong candidate for buy and hold2025 Top Decliners & AI Driven Stock Movement Reports - baoquankhu1.vn
Aug Breakouts: Can Xencor Inc disrupt its industry2025 Technical Patterns & Low Risk High Reward Ideas - baoquankhu1.vn
Insider Buy: Can Xencor Inc sustain its profitabilityJuly 2025 Summary & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Retail Trends: Is Xencor Inc impacted by rising rates2025 Historical Comparison & Consistent Profit Trading Strategies - baoquankhu1.vn
Resistance Check: What is the long term forecast for Xencor Inc stock2025 Key Highlights & Community Consensus Picks - baoquankhu1.vn
Xencor, Inc. $XNCR Shares Sold by Vanguard Group Inc. - MarketBeat
Dahiyat, Xencor CEO, sells $80k in XNCR stock By Investing.com - Investing.com Australia
3,244-share sale planned by XNCR (NASDAQ: XNCR) — insider notice - Stock Titan
Insider sale and restricted vesting reported by Company (NASDAQ: XNCR) - Stock Titan
Xencor SVP Eckert sells $17,747 in shares By Investing.com - Investing.com Australia
Xencor faces royalty dispute with Alexion over Ultomiris sales By Investing.com - Investing.com Australia
Xencor (NASDAQ:XNCR) Shares Gap Down Following Insider Selling - MarketBeat
Xencor falls on royalty row with AstraZeneca (XNCR:NASDAQ) - Seeking Alpha
Royalty Rift: Alexion Cuts Off US Royalty Payments To Xencor - Bitget
Xencor (NASDAQ:XNCR) VP Sells $31,689.70 in Stock - MarketBeat
Insider Selling: Xencor (NASDAQ:XNCR) SVP Sells 1,492 Shares of Stock - MarketBeat
Xencor sr. VP Desjarlais sells $31,676 in stock By Investing.com - Investing.com South Africa
Xencor sr. VP Desjarlais sells $31,676 in stock - Investing.com Nigeria
Dahiyat, Xencor CEO, sells $80k in XNCR stock - Investing.com
Xencor: Buy Rating Reaffirmed on Pipeline Momentum Despite Ultomiris Royalty Headwind - TipRanks
Xencor Updates Outlook Amid Ultomiris Royalty Dispute - TipRanks
Xencor says Alexion disputes U.S. Ultomiris royalties; updates cash guidance to $380–400M - TradingView
Xencor Announces Change to Ultomiris® Royalty Revenue Forecast - Business Wire
XNCR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
(XNCR.O) | Stock Price & Latest News - Reuters
[144] Xencor Inc SEC Filing - Stock Titan
John Desjarlais plans to sell 2,663 XNCR shares (XNCR) — Form 144 notice - Stock Titan
Xencor at TD Cowen Conference: Strategic Focus on Oncology and Autoimmune - Investing.com Nigeria
Update Recap: Should value investors consider Xencor IncEarnings Recap Report & High Yield Equity Trading Tips - baoquankhu1.vn
Xencor, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Responsive Playbooks and the XNCR Inflection - Stock Traders Daily
XNCR PE Ratio & Valuation, Is XNCR Overvalued - Intellectia AI
Xencor (NASDAQ:XNCR) Stock Rating Lowered by Wall Street Zen - MarketBeat
Xencor, Inc. (XNCR) Investor Outlook: Unpacking the 113% Potential Upside in Biotech Innovation - DirectorsTalk Interviews
Xencor, Inc. $XNCR Shares Purchased by Primecap Management Co. CA - MarketBeat
Analysts Offer Insights on Healthcare Companies: Xencor (XNCR), Agilon Health (AGL) and Privia Health Group (PRVA) - The Globe and Mail
Barclays Raises Xencor (XNCR) Price Target to $27, Maintains Ove - GuruFocus
Xencor (NASDAQ:XNCR) Shares Up 10.4% After Better-Than-Expected Earnings - MarketBeat
Xencor (NASDAQ:XNCR) Given New $27.00 Price Target at Barclays - MarketBeat
Xencor Inc earnings beat by $0.51, revenue fell short of estimates - Investing.com Nigeria
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):